These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35353497)

  • 1. Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects.
    Shinchi H; Komaki F; Yuki M; Ohara H; Hayakawa N; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Chem Biol; 2022 Apr; 17(4):957-968. PubMed ID: 35353497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyco-Nanoadjuvants: Sugar Structures on Carriers of a Small Molecule TLR7 Ligand Affect Their Immunostimulatory Activities.
    Shinchi H; Yuki M; Yamauchi T; Niimura M; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Appl Bio Mater; 2021 Mar; 4(3):2732-2741. PubMed ID: 35014312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands.
    Baba A; Wakao M; Shinchi H; Chan M; Hayashi T; Yao S; Cottam HB; Carson DA; Suda Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126840. PubMed ID: 31864800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity.
    Huang CH; Mendez N; Echeagaray OH; Weeks J; Wang J; Vallez CN; Gude N; Trogler WC; Carson DA; Hayashi T; Kummel AC
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26637-26647. PubMed ID: 31276378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response.
    Wan D; Que H; Chen L; Lan T; Hong W; He C; Yang J; Wei Y; Wei X
    Nano Lett; 2021 Oct; 21(19):7960-7969. PubMed ID: 34533963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the Nuclease Resistance and Immunostimulatory Activity of CpG Oligodeoxynucleotides by Conjugation to Sugar-Immobilized Gold Nanoparticles.
    Murata K; Harayama K; Shimoda M; Niimura M; Wakao M; Suda Y; Moroishi T; Shinchi H
    Bioconjug Chem; 2024 Jun; 35(6):804-815. PubMed ID: 38718344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of PEGylated toll like receptor 7 ligands.
    Chan M; Hayashi T; Mathewson RD; Yao S; Gray C; Tawatao RI; Kalenian K; Zhang Y; Hayashi Y; Lao FS; Cottam HB; Carson DA
    Bioconjug Chem; 2011 Mar; 22(3):445-54. PubMed ID: 21338093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy.
    Jung E; Chung YH; Steinmetz NF
    Bioconjug Chem; 2023 Sep; 34(9):1596-1605. PubMed ID: 37611278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant.
    Euliano EM; Pogostin BH; Agrawal A; Yu MH; Baryakova TH; Graf TP; Hartgerink JD; McHugh KJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-pot synthesis and characterization of ovalbumin-conjugated gold nanoparticles: A comparative study of adjuvanticity against the physical mixture of ovalbumin and gold nanoparticles.
    Yang Y; Zhang Y; Thakur A; Li R; Xu H; Wang Z; Ghavami M; Tu Z; Liu H
    Int J Pharm; 2019 Nov; 571():118704. PubMed ID: 31536763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-Cholesterol Nanoparticles Function as Potent Immune Activators
    Obermann HL; Lederbogen II; Steele J; Dorna J; Sander LE; Engelhardt K; Bakowsky U; Kaufmann A; Bauer S
    Front Immunol; 2021; 12():658895. PubMed ID: 35126343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery.
    Lin SF; Jiang PL; Tsai JS; Huang YY; Lin SY; Lin JH; Liu DZ
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1228-1237. PubMed ID: 30339742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation.
    Gadd AJR; Castelletto V; Kabova E; Shankland K; Perrie Y; Hamley I; Cobb AJA; Greco F; Edwards AD
    Eur J Pharm Sci; 2018 Oct; 123():268-276. PubMed ID: 30048801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
    Chan M; Hayashi T; Kuy CS; Gray CS; Wu CC; Corr M; Wrasidlo W; Cottam HB; Carson DA
    Bioconjug Chem; 2009 Jun; 20(6):1194-200. PubMed ID: 19445505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation.
    Mottas I; Bekdemir A; Cereghetti A; Spagnuolo L; Yang YS; Müller M; Irvine DJ; Stellacci F; Bourquin C
    Biomaterials; 2019 Jan; 190-191():111-120. PubMed ID: 30415018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity.
    Wilson DS; Hirosue S; Raczy MM; Bonilla-Ramirez L; Jeanbart L; Wang R; Kwissa M; Franetich JF; Broggi MAS; Diaceri G; Quaglia-Thermes X; Mazier D; Swartz MA; Hubbell JA
    Nat Mater; 2019 Feb; 18(2):175-185. PubMed ID: 30643235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.